arrow
A

Andrew Gorringe

UK Health Security Agency
H指数:36
被引数:4,279

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety, colonisation kinetics, transmissibility, and immune correlates of protection in healthy adults inoculated with Bordetella pertussis in England: a single-centre, open-label, phase 1, controlled human infection study

安全性、定植动力学、传染性和保护性免疫相关性在接种了Bordetella pertussis的英国健康成年人中的研究:一项单中心、开放标签、1期、受控人体感染研究

2026-03-230
OAAI
Highlights of the 14th International Bordetella Symposium

第十四届国际博德特菌 Symposium 的亮点

MSPHERE
IF3.1
2025-05-160
OA
Epidemiology of Group B Streptococcus: Maternal Colonization and Infant Disease in Kampala, Uganda
2025-04-010
OAAI
Diversity in Naturally Acquired Immunity to Group B Streptococcus: A Comparative Study of Women From Bangladesh, Malawi, and the United Kingdom

对B组链球菌的自然获得性免疫的多样性: 来自孟加拉国,马拉维和英国的妇女的比较研究

2024-12-180
PRE
Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides

测量针对六组B链球菌多糖的人血清IgG抗体的多重免疫测定法的实验室间比较

2024-04-120
OAAI
Towards comprehensive understanding of bacterial genetic diversity: large-scale amplifications in Bordetella pertussis and Mycobacterium tuberculosis
2022-02-233
OAAI
Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques
2021-09-1018
OAAI
A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage

重组共生细菌在咽部运输过程中引发异源抗原特异性免疫反应

2021-07-077
OA
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (vol 27, pg 279, 2021)
2021-05-066
OAAI
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
2020-12-17233
OAAI